MedTrace Logo

Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users

NCT00164372 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 1400

Last updated 2012-09-27

No results posted yet for this study

Summary

The purpose of this study is to test whether a six-session behavioral intervention for HIV and HCV seronegative injection drug users is effective in reducing sexual and injection risk behaviors that could lead to primary HIV and HCV infection.

Conditions

  • HIV Infections
  • Hepatitis C

Interventions

BEHAVIORAL

Peer Education Intervention

Sponsors & Collaborators

Principal Investigators

  • Richard S. Garfein, PhD, MPH · Centers for Disease Control and Prevention

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-05-31
Primary Completion
2006-12-31
Completion
2006-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00164372 on ClinicalTrials.gov